<DOC>
	<DOCNO>NCT00031473</DOCNO>
	<brief_summary>The purpose study test safety effectiveness ribavirin , administer aerosol , prevent progression upper respiratory tract RSV infection RSV pneumonia bone marrow peripheral blood transplant recipient .</brief_summary>
	<brief_title>Ribavirin Prevent RSV Pneumonia Bone Marrow Transplant Patients</brief_title>
	<detailed_description>The study enroll 90 transplant recipient positive nasal/throat culture specimens Respiratory Syncytial Virus ( RSV ) infection . Patients randomize one two group : investigational treatment standard treatment .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Pneumonia</mesh_term>
	<mesh_term>Virus Diseases</mesh_term>
	<mesh_term>Respiratory Syncytial Virus Infections</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Ribavirin</mesh_term>
	<criteria>INCLUSION CRITERIA : 2 year age old . Are pregnant breastfeed agree use reliable birth control method duration study . Are blood bone marrow transplant recipient . Have evidence upper respiratory tract infection . Have nasopharyngealthroat sample positive RSV . EXCLUSION CRITERIA : Are know HIV positive . Have pneumonia . Require ventilator breathe . Are pregnant . Are breastfeed unwilling stop breastfeeding . Are receive treatment certain drug RSV .</criteria>
	<gender>All</gender>
	<minimum_age>5 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>December 2003</verification_date>
	<keyword>Ribavirin</keyword>
	<keyword>RSV</keyword>
</DOC>